XML 11 R4.htm IDEA: XBRL DOCUMENT v3.25.3
Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Operating expenses:        
Research and development $ 5,430,757 $ 12,441,509 $ 21,359,309 $ 33,594,761
General and administrative 2,570,375 3,696,067 7,238,014 9,944,487
Loss from operations (8,001,132) (16,137,576) (28,597,323) (43,539,248)
Other income (expense):        
Interest income 788,694 1,503,845 2,642,220 4,951,949
Interest expense (475,903) (479,252) (1,430,051) (1,455,378)
Total other income, net 312,791 1,024,593 1,212,169 3,496,571
Net loss $ (7,688,341) $ (15,112,983) $ (27,385,154) $ (40,042,677)
Net loss per share - basic $ (0.13) $ (0.25) $ (0.46) $ (0.67)
Net loss per share - diluted $ (0.13) $ (0.25) $ (0.46) $ (0.67)
Weighted average common shares outstanding - basic 60,126,850 59,530,113 60,020,763 59,453,312
Weighted average common shares outstanding - diluted 60,126,850 59,530,113 60,020,763 59,453,312